Gland Pharma Q4 Results: Firm misses profit view on higher employee costs
Indian generic injectables maker Gland Pharma reported fourth-quarter profit below estimates on Wednesday, as soaring employee expenses outweighed strong demand in its core markets. It reported a consolidated net profit of 1.92 billion rupees ($23 million) for the quarter ended March 31, missing analysts’ average estimate of 2.41 billion rupees as per LSEG data. In…
